|
1
|
Moertel CG, Fleming TR, Macdonald JS,
Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA,
Tormey DC, Glick JH, et al: Levamisole and fluorouracil for
adjuvant therapy of resected colon carcinoma. N Engl J Med.
322:352–358. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
André T, Boni C, Navarro M, Tabernero J,
Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F
and de Gramont A: Improved overall survival with oxaliplatin,
fluorouracil, and leucovorin as adjuvant treatment in stage II or
III colon cancer in the MOSAIC trial. J Clin Oncol. 27:3109–3116.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haller DG, Tabernero J, Maroun J, de Braud
F, Price T, Van Cutsem E, Hill M, Gilberg F, Rittweger K and
Schmoll HJ: Capecitabine plus oxaliplatin compared with
fluorouracil and folinic acid as adjuvant therapy for stage III
colon cancer. J Clin Oncol. 29:1465–1471. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shin NY, Kim MJ, Lim JS, Park MS, Chung
YE, Choi JY, Kim KW and Park YN: Accuracy of gadoxetic
acid-enhanced magnetic resonance imaging for the diagnosis of
sinusoidal obstruction syndrome in patients with
chemotherapy-treated colorectal liver metastases. Eur Radiol.
22:864–871. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim SH, Park SJ, Lee SA, Lee WJ, Park JW
and Kim CM: Isolated caudate lobectomy using the hanging maneuver.
Surgery. 139:847–850. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rubbia-Brandt L, Audard V, Sartoretti P,
Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane
O, Chaussade S, et al: Severe hepatic sinusoidal obstruction
associated with oxaliplatin-based chemotherapy in patients with
metastatic colorectal cancer. Ann Oncol. 15:460–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
DeLeve LD, Shulman HM and McDonald GB:
Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome
(veno-occlusive disease). Semin Liver Dis. 22:27–42. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morine Y, Shimada M and Utsunomiya T:
Evaluation and management of hepatic injury induced by
oxaliplatin-based chemotherapy in patients with hepatic resection
for colorectal liver metastasis. Hepatol Res. 44:59–69. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aloia T, Sebagh M, Plasse M, Karam V, Lévi
F, Giacchetti S, Azoulay D, Bismuth H, Castaing D and Adam R: Liver
histology and surgical outcomes after preoperative chemotherapy
with fluorouracil plus oxaliplatin in colorectal cancer liver
metastases. J Clin Oncol. 24:4983–4990. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arakawa Y, Shimada M, Utsunomya T, Imura
S, Morine Y, Ikemoto T, Hanaoka J, Sugimoto K and Bando Y:
Oxaliplatin-related sinusoidal obstruction syndrome mimicking
metastatic liver tumors. Hepatol Res. 43:685–689. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Uchino K, Fujisawa M, Watanabe T, Endo Y,
Nobuhisa T, Matsumoto Y, Kai K, Sato S, Notohara K and Matsukawa A:
Oxaliplatin-induced liver injury mimicking metastatic tumor on
images: A case report. Jpn J Clin Oncol. 43:1034–1038. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van den Broek MA, Vreuls CP, Winstanley A,
Jansen RL, van Bijnen AA, Dello SA, Bemelmans MH, Dejong CH,
Driessen A and Olde Damink SW: Hyaluronic acid as a marker of
hepatic sinusoidal obstruction syndrome secondary to
oxaliplatin-based chemotherapy in patients with colorectal liver
metastases. Ann Surg Oncol. 20:1462–1469. 2013. View Article : Google Scholar : PubMed/NCBI
|
